Dr Bonny Parkinson

Dr Bonny Parkinson

Senior Research Fellow

Dr Bonny Parkinson
Senior Research Fellow

Contact Details
Phone: +612 9850 2486
Email: bonny.parkinson@mq.edu.au
Address: Suite 3-4, Level 1, EMCBuilding
3 Innovation Road, Macquarie Park 2109

Research interests
Pharmaceutical policy 
Economic evaluations of healthcare


Bonny is a Senior Research Fellow at MUCHE. Prior to joining MUCHE she was a Research Fellow at the Centre for Health Economics, Research and Evaluation at the University of Technology Sydney (UTS) for six years. She has also worked at AstraZeneca in the United Kingdom as a senior health economist, Access Economics in Canberra as a senior economist, and the Social Policy Evaluation and Research Centre at the Australian National University as an Assistant researcher.

Bonny’s expertise is in pharmaceutical policy in Australia, conducting and reviewing economic evaluations of healthcare interventions and technologies, and analysing linked administrative data to inform economic evaluations. Dr Parkinson leads a team of researchers conducting evaluations of submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) and researching economic evaluation methodology. She is currently a member of the Ezetimibe Review Reference Group for the Australian Government Department of Health (2016-2017). She has published 12 peer-reviewed journal articles and 15 non-peer-reviewed publications; and presented at 14 conferences. Her PhD was on “Pharmaceutical Policy in Australia: Developing Methods to Manage Uncertainty in Health Technology Assessment”, for which she received the UTS Chancellor’s List award in 2016.

During her time at UTS she conducted numerous evaluations of submissions to the PBAC, the Medical Services Advisory Committee (MSAC) and the National Diabetes Subsidy Scheme (NDSS). For this work she was awarded the UTS Research Excellence Through Partnership award in 2013. In recognition of her expertise in reviewing economic evaluations, she was an invited member of the international Delphi panel which developed the AdViSHE tool – a tool that can be used to assess the validation status of health economic decision models.

Bonny has excellent skills in presenting complex economic research in ways that captivates an audience’s attention and is understandable. She teaches health economics as of the Masters of Public Health and regularly teaches short courses on economic evaluation.  In 2014 she was invited by the Australian Chapter of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) workshop ‘Risky Business: Decision Making in Healthcare with Economic Uncertainty’.

Bonny was also an executive member of the Australian Health Economics Society (AHES) committee (2012-2016). In 2015-2016 she was acting secretary and was involved with organising the 2015 AHES conference. She is currently co-organising the 2017 AHES conference in Sydney. In 2013 and 2014, Bonny co-conceived and co-organised the first and second Australian Health Economics Doctoral workshop. The feedback from participants was very positive in the first two years that the workshop is now a permanent fixture of the annual Australian Health Economics Society conference.

Publications and reports

  • Thathya, V. A., Zanfina A., Huq, M., Rosenfeldt, F., Duffy, S.J., Parkinson, B., Yap, C., Smith, J., Billah, B., Yan, B.P., Brennan, A., Tran, L., Reid, C. The real-world cost-effectiveness of coronary artery bypass surgery versus stenting in high-risk patients: Propensity score-matched analusis of a single-centre experience. Applied Health Economics and Health Policy (2018) https://doi.org/10.1007/s40258-018-0407-5
  • Parkinson, B., Brown, P., Boyages, J., Cameron, LD., Elder, E., Lam, T., Shaw, LE., Sherman, KA. (In Press) Cost-effectiveness of the BRECONDA decision aid for breast reconstruction: lessons for economic evaluations of patient decision aids. Psycho-oncology
  • Saing, S., Parkinson, B., Church, J., Goodall, S,. (In Press) Cost effectiveness of a community delivered consultation to improve infant sleep problems and maternal well-being. Value in Health, Regional Issues
  • Boyages, J., Xu, Y., Kalfa, S., Koelmeyer. L., Parkinson, B., Mackie, H., Viveros, H., Gollan, P., Taksa, L. The Financial Cost of Lymphedema Borne by Women with Breast Cancer, Psycho-Oncology (epub ahead of print).
  • Cronin, P. Kirkbride, B., Bang, A., Parkinson, B., Smith, D.P., Patel M., Haywood, P. Long-term health care costs for patients with prostate cancer: A population-wide longitudinal study in New South Wales Australia, Asia-Pacific Journal of Clinical Oncology (epub ahead of print)
  • Parkinson, B., Viney, R., Pearson, SA., Haas, M., Goodall, S., Srasuebkul, P., Real world evidence: a comparison of the Australian Herceptin Program and clinical trials of trastuzumab for HER2+ metastatic breast cancer, Pharmacoeconomics, 34(10): 1039-50.
  • Parkinson, B., Elshaug, AG., Authors’ Reply to Palozzo and Messori: ‘‘Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review’’, Pharmacoeconomics, 34(4):421-2.
  • Parkinson, B., Sermet, C., Clement, F., Crausaz, S., Godman, B., Garner, S., Choudhury, M., Pearson, SA., Viney, R., Lopert, R., Elshaug, AG. Value-Based Purchasing and Disinvestment Strategies for Pharmaceuticals: An International Review, Pharmacoeconomics, 33(9):905-24 (2015)
  • Langton, J., Srasuebkul, P., Reeve, R.D., Parkinson, B., Gu, Y., Buckley, N., Haas, M.R., Viney, R.C. & Pearson, S. 2014, 'Resource use costs and quality of end of life care: Observations in a cohort of elderly Australian cancer decedents', Implementation Science, 10:25 (2015)
  • Parkinson B., Pearson SA, Viney R. (2014) ‘Economic evaluations of trastuzumab in HER2 positive metastatic breast cancer: a systematic review and critique’, European Journal of Health Economics, 15(1): 93-112 (2014)
  • Parkinson B., Goodall S. & Thavaneswaran P. 2013, 'The cost-effectiveness of lumbar artificial intervertebral disc replacement', ANZ Journal Of Surgery, 83(9): 669-675 (2013)
  • Parkinson B., Norman R, Goodall S (2013), ‘Measuring Loss of Consumer Choice in Mandatory Health Programmes Using Discrete Choice Experiments’, Applied Health Economics and Health Policy, 11 (2): 139-150. (2013)
  • Rabovskaja V, Parkinson B, Goodall S. ‘The cost-effectiveness of mandatory folic acid fortification in Australia: An updated retrospective economic evaluation’. Journal of Nutrition, 143 (1): 59-66 (2013)
  • Parkinson B., Goodall S, ‘Considering consumer choice in the economic evaluation of mandatory health programmes: A review’, Health Policy, 101(3): 236-244. (2011)
  • Vallejo-Torres L, Steuten L, Parkinson B., Girling A and Buxton M, ‘Integrating Health Economics in the Development Cycle of Medical Devices: The Case Study of Absorbable Pins’, Medical Decision Making, 31: 596-610. (2011)
  • De Abreu Lourenco, R. Haywood, P., Parkinson, B., Van Gool, K., Viney, R. The Economic Implications of a Genomically Guided Approach to Cancer Care in Australia. A report for the NSW Cancer Council (Forthcoming)
  • Parkinson B., De Abreu Lourenco R. Discounting in Economic Evaluations in Health Care: A brief review, CREST Factsheet. (2015)
  • Parkinson, B. 'Pharmaceutical policy in Australia. CHERE Working Paper 2013/01'. (2013)
  • Parkinson, B., Goodall, S., Norman, R., 'Measuring the loss of consumer choice in mandatory health programs using Discrete Choice Experiments. CHERE Working Paper 2012/04'. (2012)
  • Van Gool K, Parkinson B., Kenny P. Medicare Australia data for research: an introduction, CREST Factsheet. (2011)
  • Parkinson, B., Goodall, S. & Cameron, A. 'Artificial intervertebral disc replacement in patients with cervical degenerative disc disease. MSAC Application 1145', MSAC, Canberra. (2011)
  • Parkinson, B., Goodall, S. & Cameron, A., 'Review of interim funded services: Artificial Intervertebral Disc Replacement - Lumbar: MSAC Reference 1090.1', MSAC, Canberra. (2011)
  • Access Economics. The Cost of Cancer in NSW, Report to Cancer Council NSW (2007)
  • Access Economics. The Economic Costs of Crohn's Disease and UlcerativeColitis, Report to the Australian Crohn’s and Colitis Association. (2007)
  • Access Economics. Living with Parkinson's Disease: Challenges & positive for the future, Report to Parkinson’s Australia. (2007)
  • Access Economics. The Health Economics of Chemoprevention for breast in Australia, Report to the NSW Cancer Institute (2007)
  • Access Economics. Cost-Effectiveness Measures in Public Financing Decisions, Report to Roche, Australia (2007)
  • Access Economics. Road and Rail Neutrality and Efficiency: In the Farm to Port Logistics Chain, Report to the Rural Industries Research and Development Corporation. (2007)
  • Access Economics. Centrally Focussed: The Impact of Age Related Macular Degeneration, Report to the Centre of Eye Research Australia. (2006)
  • Access Economics. The Cost of Domestic Violence to the Australian Economy, Report to the Office for the Status of Women. (2004)
Back to the top of this page